Studies conducted on four types of colon and gastric cancer cell lines showed that MYR modulates cell apoptosis and autophagy by suppressing the PI3K/Akt/mTOR signaling pathway and increasing the LC3-II/β-actin ratio and Beclin-1/β-actin expression [42,47,111]. This evidence concerns the gene AKT1 and gastric cancer.